Literature DB >> 6109433

Hypoglycemia in Alzheimer's disease.

R Adolfsson, G Bucht, F Lithner, B Winblad.   

Abstract

Glucose tolerance tests (GTT) were performed on patients with a) dementia of Alzheimer type, b) distal gangrene, c) cerebrovascular disease, and d) on non-diabetic controls. Fasting blood sugar was significantly lower and the areas under the GTT curves were significantly smaller in the dementia group than in the other three groups. It is discussed whether Alzheimer's disease is a generalized disease not only confined to brain tissue and whether the reduced blood glucose levels could impair the brain transmitter levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6109433     DOI: 10.1111/j.0954-6820.1980.tb01217.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  10 in total

1.  [Hypoglycemia despite hyperglycemia. Is a cerebral glucose deficiency possible even with raised blood sugar levels?].

Authors:  G Erdös; R Lobmann; B Wolcke; C Werner
Journal:  Anaesthesist       Date:  2005-07       Impact factor: 1.041

Review 2.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

Review 3.  Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal.

Authors:  Rajat Sandhir; Smriti Gupta
Journal:  World J Diabetes       Date:  2015-09-25

4.  Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

Authors:  R E Tato; A Frank; A Hernanz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 5.  Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2012-01-01       Impact factor: 9.546

Review 6.  Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

Review 7.  Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.

Authors:  Suzanne M de la Monte
Journal:  Curr Alzheimer Res       Date:  2012-01       Impact factor: 3.498

8.  Impact of dementia on diabetic care in the aged.

Authors:  A J Bayer; J Johnston; A J Sinclair
Journal:  J R Soc Med       Date:  1994-10       Impact factor: 18.000

9.  Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease.

Authors:  Zohara Sternberg; Zihua Hu; Daniel Sternberg; Shayan Waseh; Joseph F Quinn; Katharine Wild; Kaye Jeffrey; Lin Zhao; Michael Garrick
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

10.  White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model.

Authors:  Nadezda Ivanova; Qingfan Liu; Cansu Agca; Yuksel Agca; Earl G Noble; Shawn Narain Whitehead; David Floyd Cechetto
Journal:  J Neuroinflammation       Date:  2020-01-21       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.